SCHEMBL7960177

SCHEMBL7960177

Cc1ncccc1C(=O)N1CCCCC1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
TSHR P16473 2/20 0.47
ALDH1A1 P00352 3/20 0.45
CA2 P00918 1/20 0.44
ITGB3 P05106 1/20 0.43
ITGB1 P05556 1/20 0.43
ITGAV P06756 1/20 0.43
ITGA5 P08648 1/20 0.43
ITGA4 P13612 1/20 0.43
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PDE2A O00408 1/20 0.41
KDM4E B2RXH2 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7852753 0.86 TDP1 (0.49) TDP1L3MBTL1TSHRALDH1A1CA2
SCHEMBL7946512 0.85 NAPRT (0.48) TDP1L3MBTL1TSHRALDH1A1CA2
SCHEMBL7957115 0.85 SMN1; SMN2 (0.48) TDP1L3MBTL1TSHRALDH1A1CA2
SCHEMBL7954849 0.84 POLB (0.51) TSHRALDH1A1HCRTR2POLBSMN1; SMN2
SCHEMBL17600704 0.81 LMNA (0.53) HCRTR1HCRTR2POLBRAB9A
SCHEMBL17600705 0.81 LMNA (0.53) HCRTR1HCRTR2POLBRAB9A
SCHEMBL5909267 0.80 KMT2A (0.53) TDP1TSHRALDH1A1CA2HCRTR1
SCHEMBL6265889 0.79 HSD11B1 (0.56)
SCHEMBL20858858 0.78 ITGB1 (0.67) L3MBTL1ALDH1A1CA2ITGB3ITGB1
SCHEMBL3175587 0.77 DGAT1 (0.54) TDP1L3MBTL1TSHRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194426-B1 CONTROLLING TUMOR NECROSIS FACTOR RHONA-POULENC RORER S.A. (FR) 2001-02-27 US disclosed
WO-1998025612-A1 NOVEL THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1998-06-18 WO disclosed